Bio-Techne CorporationTECHNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank21
3Y CAGR-31.1%
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-31.1%/yr
vs -5.0%/yr prior
Acceleration
-26.1pp
Decelerating
Percentile
P21
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20255.54%
202411.60%
20233.96%
202216.93%
202120.36%
2020-8.88%
20199.86%
201820.78%
201741.43%
201617.99%